山(shan)(shan)東(dong)(dong)金(jin)城(cheng)醫藥(yao)(yao)(yao)集團股(gu)(gu)份有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)(簡稱“金(jin)城(cheng)醫藥(yao)(yao)(yao)”,股(gu)(gu)票代(dai)碼:300233)成立于(yu)2004年(nian),創(chuang)業(ye)板上市企業(ye)。目前,公(gong)(gong)(gong)(gong)司(si)(si)(si)擁有(you)(you)(you)北京朗依制藥(yao)(yao)(yao)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、上海金(jin)城(cheng)藥(yao)(yao)(yao)業(ye)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、廣東(dong)(dong)金(jin)城(cheng)金(jin)素制藥(yao)(yao)(yao)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、山(shan)(shan)東(dong)(dong)金(jin)城(cheng)生(sheng)物藥(yao)(yao)(yao)業(ye)有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、山(shan)(shan)東(dong)(dong)金(jin)城(cheng)醫藥(yao)(yao)(yao)化工有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、山(shan)(shan)東(dong)(dong)金(jin)城(cheng)石墨(mo)烯科技有(you)(you)(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)、意大利海寶露有(you)(you)(you)限(xian)責任公(gong)(gong)(gong)(gong)司(si)(si)(si)等18家參(can)控股(gu)(gu)公(gong)(gong)(gong)(gong)司(si)(si)(si)。公(gong)(gong)(gong)(gong)司(si)(si)(si)通過“實業(ye)+資(zi)本”雙輪驅動發展模(mo)式(shi),已構建形(xing)成獨具金(jin)城(cheng)特(te)色的醫藥(yao)(yao)(yao)健(jian)康制藥(yao)(yao)(yao)工業(ye)產(chan)業(ye)鏈,業(ye)務范(fan)圍涉及生(sheng)物制藥(yao)(yao)(yao)、頭孢類(lei)醫藥(yao)(yao)(yao)中間(jian)體、特(te)色原料藥(yao)(yao)(yao)、終端制劑、保健(jian)品(pin)、新(xin)材料等產(chan)業(ye)領域,并現已形(xing)成年(nian)營業(ye)收入超(chao)20億元、總(zong)資(zi)產(chan)近50億的產(chan)業(ye)規模(mo)。
山(shan)東金城醫藥(yao)集團(tuan)股份(fen)有限(xian)公(gong)司是以三(san)、四代頭孢類醫藥(yao)中間(jian)體、特色原料藥(yao)、生(sheng)物制(zhi)(zhi)藥(yao)、終(zhong)端制(zhi)(zhi)劑以及婦兒產品(pin)等為主(zhu)業的科研、生(sheng)產企業,其(qi)中,頭孢類醫藥(yao)中間(jian)體產品(pin)銷(xiao)量、銷(xiao)售(shou)收入連續多年位居行業前列,是重要(yao)的生(sheng)物制(zhi)(zhi)藥(yao)生(sheng)產基地以及國內醫藥(yao)健康(kang)產業集團(tuan)。主(zhu)導(dao)產品(pin)有谷胱(guang)甘肽(花青肽美品(pin)牌)、硝呋太爾(er)膠(jiao)囊(nang)(nang)(朗依品(pin)牌)、富(fu)馬酸比索洛(luo)爾(er)膠(jiao)囊(nang)(nang)(洛(luo)雅(ya)品(pin)牌)、牡蠣碳酸鈣咀嚼(jiao)片(pian)(金娃寧(ning)品(pin)牌)、復方木香鋁鎂(mei)片(pian)(德瑞夫(fu)品(pin)牌)等近百種(zhong)。
當前(qian),公司(si)(si)堅(jian)持科(ke)學發(fa)展(zhan),按(an)照“大(da)健(jian)(jian)康、大(da)醫藥(yao)(yao),打造(zao)具(ju)有金城特(te)色(se)(se)制(zhi)(zhi)(zhi)藥(yao)(yao)產(chan)(chan)業鏈(lian)(lian)”的產(chan)(chan)業定(ding)位(wei)和(he)(he)(he)“調(diao)整、轉型(xing)、升級、發(fa)展(zhan)”的戰略思路,專注專注金城特(te)色(se)(se)制(zhi)(zhi)(zhi)藥(yao)(yao)產(chan)(chan)業鏈(lian)(lian)三大(da)方向建設——“頭孢(bao)類抗生(sheng)素終端(duan)制(zhi)(zhi)(zhi)劑產(chan)(chan)業鏈(lian)(lian),多(duo)肽類特(te)色(se)(se)生(sheng)物制(zhi)(zhi)(zhi)藥(yao)(yao)產(chan)(chan)業鏈(lian)(lian)和(he)(he)(he)婦科(ke)、調(diao)節免疫制(zhi)(zhi)(zhi)劑特(te)色(se)(se)類產(chan)(chan)業鏈(lian)(lian) ”。同(tong)時,公司(si)(si)加快(kuai)(kuai)“三個平(ping)臺(tai)”建設(技(ji)術創(chuang)新平(ping)臺(tai)、產(chan)(chan)業運營平(ping)臺(tai)、組(zu)織管控平(ping)臺(tai)),加快(kuai)(kuai)打造(zao)“四(si)支隊(dui)(dui)伍(wu)”建設(企(qi)業家隊(dui)(dui)伍(wu)、中(zhong)高(gao)層管理隊(dui)(dui)伍(wu)、專業人才(cai)隊(dui)(dui)伍(wu)、熟(shu)練工人隊(dui)(dui)伍(wu)),積(ji)極實(shi)踐(jian)內涵式發(fa)展(zhan)、外(wai)延式擴張和(he)(he)(he)投(tou)資并購(gou)三種發(fa)展(zhan)方式,著(zhu)力將公司(si)(si)打造(zao)成“科(ke)技(ji)化、生(sheng)態化、規范(fan)化、品牌化、國際化”的現代(dai)化醫藥(yao)(yao)健(jian)(jian)康產(chan)(chan)業集團,助(zhu)推醫藥(yao)(yao)進步,創(chuang)享健(jian)(jian)康生(sheng)活,志在成為醫藥(yao)(yao)健(jian)(jian)康產(chan)(chan)業創(chuang)新型(xing)領軍企(qi)業。